Anca-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Anca-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-06-03FDA Approved: TAVNEOS — Supplemental Application (ChemoCentryx, Inc.)
The FDA approved a supplemental application for TAVNEOS (avacopan) submitted by ChemoCentryx, expanding its regulatory status for the treatm…
-
FDA approval · 2022-07-06FDA Approved: TAVNEOS — Supplemental Application (ChemoCentryx, Inc.)
The FDA approved a supplemental application for TAVNEOS (avacopan) submitted by ChemoCentryx, Inc.
-
FDA approval · 2021-10-07FDA Approved: TAVNEOS — Original Application (ChemoCentryx, Inc.)
FDA approved Tavneos (avacopan) from ChemoCentryx for adults with ANCA-associated vasculitis, in combination with standard therapy, includin…